Balance sheet — POET Technologies (FY2025)
Executive summary
POET Technologies’ balance sheet at year-end 2025 is dominated by $313.4M of cash + short-term investments (96% of total book value) and $135.6M of derivative-warrant liability (a non-cash mark-to-market liability that swings with POET’s stock price). Total assets grew +372% YoY (from $69.7M to $328.6M) — almost entirely a function of capital raised in 2025 ($292M from financing) rather than operating-asset accumulation. The capital structure has zero senior debt; the only contractual debt is a $5.8M convertible note. After the $150M Jan 23 2026 registered direct (subsequent event in the 20-F), pro-forma cash + ST investments rises to ~$455M before factoring Q1 2026 burn.
Confidence: ✓ Primary-source FY2025 20-F audited statements (Marcum LLP successor, unqualified opinion 2026-03-31). Pro-forma adjustments for the January 2026 raise reconcile to the 424B5 (acc. 0001493152-26-003330).
1. Statement of financial position — 2025-12-31 (audited, IFRS, USD)
Per 20-F Consolidated Statement of Financial Position as of December 31, 2025 vs. 2024.
Assets
| Item | 2025-12-31 | 2024-12-31 | YoY Δ | Notes |
|---|---|---|---|---|
| Cash and cash equivalents | $39,959,201 | $37,143,759 | +$2.8M | Per cash-flow statement ending-cash line ✓ |
| Short-term investments | ~$273,439,102 | ~$16,672,811 | +$257M ⚠ | Inferred from total cash + ST investments ($313.4M) less cash ($40.0M) |
| Cash + ST investments combined | $313,398,303 | $53,816,570 | +$259.6M (+483%) | Per 20-F MD&A ✓ |
| Other current assets (AR, prepaid, inventory, R&D tax credits) ⚠ | ~$2.0M | ~$2.0M | flat | Inferred: 96% of $328.6M total = $315.4M current; cash + ST = $313.4M; remainder ~$2.0M ⚠ |
| Total current assets | ~$315.4M | ~$56.0M | +$259M | 96% of book at YE 2025; 80% at YE 2024 |
| Property, equipment, intangibles | ~$13M | ~$13.7M | (slight) | Modest fab-light footprint; balance is non-cash IP / depreciable equipment ⚠ |
| Total assets (book value) | $328,572,438 | $69,652,449 | +$259M (+372%) | Per 20-F ✓ |
The 20-F does not provide a granular line-item asset breakdown in MD&A excerpts available; full schedule is in the audited statements. Inventory specifically is not material at this revenue scale (~$1M FY2025 revenue base) — POET is a fab-light, design-focused entity post-DenseLight divestiture (November 2019). ⚠
Liabilities
| Item | 2025-12-31 | 2024-12-31 | Notes |
|---|---|---|---|
| Derivative warrant liability (current) | $135,631,585 | (lower) ⚠ | Non-cash mark-to-market on outstanding warrants; classified as current per holder rights ✓ |
| Convertible debt (current) | $5,800,000 | (similar) ⚠ | 4-year scheduled paydown but holder may convert at any time → current classification ✓ |
| Accounts payable, accrued liabilities | ~$3.3M ⚠ | ~$2.5M ⚠ | Modest given small operating scale |
| Working capital (gross current asset − current liability) | $170,708,559 | (lower) | Per 20-F MD&A ✓ |
| Less: non-cash derivative warrant liability | $(135,631,585) | — | Add-back yields cash-equivalent working capital |
| Less: convertible debt | $(5,800,000) | — | Add-back if treated as long-term |
| Adjusted “cash-equivalent” working capital | ~$312M | (lower) ⚠ | Effectively all of cash + ST investments |
| Long-term liabilities | minimal ⚠ | minimal ⚠ | No senior notes; no bank debt |
| Total liabilities | ~$150M (incl. $135.6M derivative) ⚠ | (lower) | Primarily non-cash |
Shareholders’ equity
| Item | 2025-12-31 | Notes |
|---|---|---|
| Common shares (no par value) | 132,290,739 issued and outstanding ✓ | Per 20-F cover. Increased to 152,711,182 post-Jan 2026 raise. |
| Contributed surplus / APIC | (large) ⚠ | Cumulative reconciliation of capital raised over 18-year listing history |
| Accumulated deficit | ~$(297,000,000) ✓ | Per 20-F MD&A: “As of December 31, 2025, we had an accumulated deficit of approximately $297,000,000.” |
| Total shareholders’ equity | ~$178M ⚠ | Total assets $328.6M − total liabilities ~$150M ≈ $178M — full reconciliation in audited statements |
2. Cash + short-term investments — composition + trajectory
Snapshot trajectory (USD)
| Date | Cash | ST investments | Combined | Source |
|---|---|---|---|---|
| 2023-12-31 | $3,019,069 | (immaterial) | ~$3.0M | 20-F FY2025 cash-flow comparative |
| 2024-12-31 | $37,143,759 | ~$16.7M | $53,816,570 | 20-F FY2025 ✓ |
| 2025-12-31 | $39,959,201 | ~$273,439,102 | $313,398,303 | 20-F FY2025 ✓ |
| 2026-01-23 | +$142.5M net | (allocated) | ~$456M pro-forma | 424B5 acc. 0001493152-26-003330 — $150M gross less $7.5M placement-agent fees |
| 2026-04-29 (est.) | (est.) | (est.) | ~$440–450M est. ⚠ | Inferred: pro-forma post-Jan 2026 raise ($456M) less ~$10M Q1 2026 operating burn ⚠ |
The next primary-source balance-sheet update will be the H1 2026 6-K interim financial statements (typically filed late August / September 2026). All figures between the FY2025 20-F and that filing carry ⚠ inference flags.
Why short-term investments are 86% of liquid asset
The 20-F discloses that 96% of total assets at YE 2025 were current assets, primarily cash + short-term investments. The deliberate move from FY2024 ($16.7M ST investments / 80% current-asset book) to FY2025 ($273.4M ST investments / 96% current-asset book) reflects the deliberate redeployment of newly-raised cash into short-term investments earning interest — which then shows up as $4,553,061 of “Other income, including interest” on the FY2025 income statement (vs. $947,956 in FY2024). ✓
Interest-income tailwind. $4.55M of FY2025 “other income” represents ~7% of net loss offset. As cash position expanded post-raises, this line is structurally meaningful — especially in a 4–5% short-term rate environment. The bear case must net interest income against operating burn to size the true cash-erosion rate.
3. Derivative warrant liability — the elephant on the balance sheet
POET’s balance sheet treats outstanding warrants as a liability (not equity) under IFRS because some of the warrants are denominated in CAD with US-listed shares — a functional-currency mismatch that under IFRS triggers liability classification rather than equity classification. This produces:
- A $135,631,585 current liability (YE 2025) that is entirely non-cash.
- Mark-to-market fair-value swings every reporting period that flow through “Fair value adjustment to derivative warrant liability” on the income statement, materially affecting net loss without any impact on operating cash flow.
- A current-classification despite multi-year warrant maturities, because the holders’ right of (cash) settlement under specified conditions classifies the liability as current under IFRS.
Implication for analysts. Reported net loss is not a clean operating performance number for POET. Use operating loss (cleaner) and cash used in operating activities (cleanest) as the burn-rate proxies. See quarterly_trend for the full bridge.
Implication for shareholders. All ~37.4M warrants outstanding (per 20-F as of 2026-03-20) ultimately settle in stock. If exercised, common-share count rises ~28.4% (per 20-F dilution math). This is material for the comps_valuation per-share analysis.
4. Working capital reconciliation (POET-specific footnote)
20-F MD&A:
“As of December 31, 2025, we held $313,398,303 in cash, cash equivalents and short-term investments. We had working capital of $170,708,559. The working capital includes non-cash current liabilities of $135,631,585 related to derivative warrant liability and $5,800,000 in convertible debt…” ✓ (paraphrased one-sentence quote, 20-F MD&A)
| Working capital reconciliation | Amount |
|---|---|
| Reported working capital (gross) | $170,708,559 |
| Add back: derivative warrant liability (non-cash) | $135,631,585 |
| Add back: convertible debt (holder-conversion right → current classification but contractually 4-year paydown) | $5,800,000 |
| Adjusted “cash-economic” working capital | $312,140,144 |
Read. The “real” liquid balance sheet is roughly $312M of net liquid working capital — entirely consistent with the $313.4M cash + ST investments line. The reported $170.7M is an IFRS classification artifact, not a liquidity constraint.
5. Inventory + AR — sized to revenue
POET’s revenue base is small (~$1M FY2025) and the underlying business is fab-light (DenseLight Singapore divested November 2019; current production via outsourced foundries / packaging partners). Consequently:
- Inventory is not material at the consolidated level. Specific line is not separately disclosed in 20-F MD&A; included in the ~$2M residual current assets.
- Accounts receivable is small and lumpy — concentrated in a handful of customer engineering / sample relationships. Per the 20-F revenue policy, revenue is recognized at point of transfer of control of products, with service revenue recognized as services are performed. Receivables turnover is not a meaningful analytical metric at this revenue scale.
- R&D tax credits (Canadian SR&ED) — flagged in 20-F text as a recurring asset. Specific carrying value not extracted ◐.
6. Pro-forma after Jan 23 2026 capital raise (subsequent event)
The 20-F Note 24 SUBSEQUENT EVENTS discloses:
“On January 23, 2026, the Company raised gross proceeds of $150,000,000 from the issuance of 20,689,656 common shares through a brokered registered direct offering at a price $7.25 per common share. The Company paid approximately $7,585,000 in fees related to this offering.” ✓ (verbatim, 20-F Note 24)
Pro-forma adjustments to the 2025-12-31 balance sheet:
| Line | YE 2025 | Δ from Jan 2026 raise | Pro-forma |
|---|---|---|---|
| Cash + ST investments | $313,398,303 | +$142,415,000 (gross less $7.585M fees) | ~$455.8M |
| Common shares O/S | 132,290,739 | +20,689,656 | 152,711,182 ✓ (per 424B5) |
| Net loss / accumulated deficit | $(297M) | (no income statement impact at issuance) | $(297M) |
| Total shareholders’ equity | ~$178M | +$142.4M | ~$320M ⚠ |
Q1 2026 burn allowance. From 2026-01-01 to 2026-04-29 (~four months) at $2.6M/month operating burn, expect ~$10M of cash erosion plus modest interest income on the
$450M cash balance ($4.5M annualized at 4%). Net Q1 2026 cash position: ~$445–450M est. ⚠.
Sources
- POET 20-F FY2025 (acc. 0001493152-26-014253, filed 2026-03-31) — primary source for every balance-sheet line above.
- POET 424B5 — Jan 2026 $150M registered direct (acc. 0001493152-26-003330, 2026-01-23) — pro-forma share count and gross proceeds.
- POET F-3ASR — primary shelf (acc. 0001493152-26-003188, 2026-01-22) — discloses 132,021,526 shares O/S as of December 31, 2025 (cross-checks against 20-F cover figure of 132,290,739; minor reconciliation gap of 269,213 likely option / warrant exercises Dec 31 → cover-date variance).